What is the maximum recommended dose of gabapentin (Neurontin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Recommended Dose of Gabapentin

The maximum recommended dose of gabapentin is 3600 mg/day in 3 divided doses, though effective doses can range from 1800-3600 mg/day depending on the indication and patient factors. 1, 2

Dosing Guidelines by Indication

Neuropathic Pain

  • Starting dose: 100-300 mg at bedtime or 100-300 mg three times daily
  • Titration: Increase by 100-300 mg every 1-7 days as tolerated
  • Effective dose range: 1800-3600 mg/day in 3 divided doses
  • Duration of adequate trial: 3-8 weeks for titration plus 2 weeks at maximum dose 1

Postherpetic Neuralgia

  • Day 1: 300 mg once daily
  • Day 2: 600 mg/day (300 mg twice daily)
  • Day 3: 900 mg/day (300 mg three times daily)
  • Target dose: 1800 mg/day (600 mg three times daily)
  • Maximum dose: 3600 mg/day, though additional benefit beyond 1800 mg/day has not been consistently demonstrated 2

Epilepsy (Adults and Children ≥12 years)

  • Starting dose: 300 mg three times daily
  • Maintenance dose: 300-600 mg three times daily
  • Maximum dose: 3600 mg/day
  • Maximum time between doses: Should not exceed 12 hours 2

Dosage Adjustments for Special Populations

Renal Impairment

Dosage must be reduced based on creatinine clearance:

Creatinine Clearance (mL/min) Total Daily Dose Range (mg/day)
≥60 900-3600
>30-59 400-1400
>15-29 200-700
≤15 100-300

Patients on hemodialysis require supplemental post-dialysis doses 2

Elderly Patients

Lower starting doses and slower titration are recommended due to potentially decreased renal function 1, 2

Clinical Considerations

Efficacy Evidence

  • Moderate-quality evidence shows that gabapentin at doses of 1800-3600 mg/day provides good pain relief in postherpetic neuralgia and diabetic neuropathy, with 30-40% of patients achieving at least 50% pain reduction 3, 4
  • An adequate trial may require 2 months or more to determine effectiveness 1

Adverse Effects

  • Most common side effects include dizziness (19%), somnolence (14%), peripheral edema (7%), and gait disturbance (9%) 3
  • Adverse effects are typically mild to moderate and often subside within approximately 10 days from treatment initiation 5
  • Adverse events occur more frequently with gabapentin (63%) compared to placebo (49%) 3

Important Precautions

  1. Monitor for worsening mental status/sedation, especially during titration
  2. Maximum time between doses should not exceed 12 hours
  3. If discontinuing gabapentin, taper gradually over a minimum of 1 week to avoid withdrawal symptoms
  4. Half-tablets not used within 28 days of dividing should be discarded 2

Gabapentin can be administered with or without food, which provides flexibility in dosing schedules and may improve tolerability for some patients 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Gabapentin for chronic neuropathic pain in adults.

The Cochrane database of systematic reviews, 2017

Research

Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

The Cochrane database of systematic reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.